GREGORY TICE: Open Payments
NPI 1700344488 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 29 payments from 11 companies in 2025. Trend: 2023 $576 · 2024 $822 · 2025 $529
Food & beverage: $510Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| Merck Sharp & Dohme LLC | 8 | $121 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| SCPHARMACEUTICALS INC. | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: VERQUVO, FARXIGA, LEQVIO, WAINUA, FUROSCIX, INSPIRE, SHINGRIX, Ambulatory Monitoring & Diagnostics Undivided.
Industry payments across AL — which companies pay providers there.
